McKesson (MCK) is scheduled to announce Q2 earnings results on Wednesday, November 5th, after market close. The consensus EPS ...

McKesson's Q2 results may show steadier growth as strong U.S. pharmaceutical and RxTS momentum drive its expanding top line.

McKesson is expected to announce its second-quarter results next month, and analysts predict a double-digit increase in the ...

McKesson Corporation is a large player in the medical space, with a market capitalization of $75.86 billion. The company has shown attractive top-line growth, but bottom-line results have been ...

IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $0.82 per share of common stock, a 15% increase from $0.71 per share ...

McKesson (MCK) declares $0.82/share quarterly dividend, in line with previous. Forward yield 0.41% Payable Jan. 2; for ...

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2025 financial results after market close on Wednesday, August 7, 2024. The company will host a ...

Ladies and gentlemen, welcome to McKesson's Second Quarter Fiscal 2025 Earnings Conference Call. Please be advised that today's conference is being recorded at this time. I'd like to turn the ...

McKesson Corp. closed 3.08% below its 52-week high of $846.32, which the company reached on October 30th.

Except for historical information, statements in this press release related to McKesson’s proposed disposition of certain operations and assets in Europe constitute “forward-looking statements” within ...